Diamondoid derivatives for pharmaceutical use

Details Diamondoid derivatives for pharmaceutical use Diamondoid derivatives for pharmaceutical use

1993-12-15

1996-11-19

O'Sullivan, Peter

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

C-o-group doai

514461, 514561, 514642, 514661, 514662, 514691, 549341, 562498, 562499, 564281, 564459, 568368, 568373, 568817, 568818, A61K 3114, A61K 31045, A61K 3112, A61K 31195

Patent

active

055763553

ABSTRACT:
A method of inhibiting viruses in which a virus is contacted with diamondoid alcohol, ketone, ketone derivative, adamantyl amino acid, quaternary salt or combinations thereof which have antiviral properties. These diamondoid derivatives are shown to have antiviral activity against HIV.

REFERENCES:
patent: 3152180 (1964-10-01), Haaf
patent: 3257456 (1966-06-01), Smith
patent: 3342863 (1967-09-01), Hermann
patent: 3352912 (1967-11-01), Prichard
patent: 3356741 (1967-12-01), Schneider
patent: 3450761 (1969-06-01), Schneider
patent: 4724232 (1988-02-01), Rideout et al.
patent: 4956481 (1990-09-01), Gillaspey et al.
patent: 5019660 (1991-05-01), Chapman et al.
patent: 5053434 (1991-10-01), Chapman et al.
patent: 5132400 (1992-07-01), Gammill et al.
patent: 5194538 (1993-03-01), Paskas et al.
patent: 5221693 (1993-06-01), Shetty
Raymond C. Fort, Jr., Adamantane, The Chemistry of Diamond Molecules, Marcel Dekker, Inc., New York 1976, pp. 1-5, 58-59, 66-111, 120-141, 156-159, 190-231.
George A. Olah, Cage Hydrocarbons, John Wiley & Son, Inc., New York 1990, pp. 39-47, 146-149, 174.
Vodicka et al. "Characterization of Oxygen-Containing Adamantane Derivatives, etc." J. of Chromatography, 366 (1986) 382-384.
Merson, et al., "Aids, The Unanswered Questions", Science 260, 1209-1396 (1993).
Kratsutskii, et al., Chemical Abstracts 104: 130230b (1986) "Amino Acids of the Adamantane Series. I Synthesis and Antiviral Activity of Adamantane .alpha.-Amino Acids And Their Derivatives", Khim.-Farm. Zh. 19 (7), 825-9 (1985).
Larder, et al., "HIV With Reduced Sensitivity to Zidovudine (AZT) Isolated During Prolonged Therapy", Science 243:1731-1734 (1989).
Montefiori, et al., "Evaluation of Antiral Drugs and Neutralizing Antibodies to Human Immunodeficiency Virus by a Rapid and Sensitive Microtiter Infection Assay", J. Clin. Microbiol 26:231-235 (1988).
Pauwels, et al., "Rapid and Automated Tetrazolium-Based Colorimetric Assay For the Detection of Anti-HIV Compounds", J. Virol Meth. 20:309-321 (1988).
Carmichael, et al., "Evaluation of a Tetrazolium-Based Semiautomated Colorimetric Assay: Assessment of Chemosensitivity Testing", Cancer Research 47:936-942. (1987).
Tada, et al., "An Improved Colorimetric Assay For Interleukin 2", J. Immunol. Meth. 93:157-165 (1986).
Harada, et al., "Infection of HTLV-III/LAV in HTLV-I-Carrying Cells MT-2 and MT-4 and Application in a Plaque Assay", Science 229: 563-566 (1985).
R. C. Fort, Jr., Adamantane, The Chemistry of Diamond Molecules, Marcel Dekker, New York 1976, pp. 327-357.

Affiliated with

Also associated with

Rating

Diamondoid derivatives for pharmaceutical use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diamondoid derivatives for pharmaceutical use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diamondoid derivatives for pharmaceutical use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-541453